Six novel α-dicarbonyl-derived azo–hydrazones were identified as potent, bioavailable antibacterial leads with low toxicity. Their broad-spectrum inhibitory potential and drug-like profiles were confirmed via molecular docking and ADMET analyses.
Vu et al. (Thu,) studied this question.